Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis

References

• Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344–7.
   PubMed Web of Science ®Google Scholar
• Plotz PH, Dalakas M, Leff FtL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: poly-myositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111:143–57.
   PubMed Web of Science ®Google Scholar
• Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995;122:715–24.
   Google Scholar
• Dickey BF, Myers AR. Pulmonary disease in polymyositis/ dermatomyositis. Semin Arthritis Rheum 1984;14:60–76.
   PubMed Web of Science ®Google Scholar
• Frazier AR, Miller RD. Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 1974;65:403–7.
   PubMed Web of Science ®Google Scholar
• Salmeron G, Greenberg D, Lidsky SD. Polymyositis and diffuse interstitial lung disease: a review of the pulmonary histopathologic findings. Arch Intern Med 1981;141:1005–10.
   PubMedGoogle Scholar
• Schwarz MI. Pulmonary and cardiac manifestations of poly-myositis-dermatomyositis. J Thorac Imaging 1992;7:46–54.
   PubMed Web of Science ®Google Scholar
• Lakhanpal S, Lie JT, Conn DL, Martin WJ II. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987;46: 23–9.
   Google Scholar
• Maugars YM, Berthelot JMM, Abbas AA, Mussini JMD, Nguyen JMD, Prost AM. Long-term prognosis of 69 patients with dermato-myositis and polymyositis. Clin Exp Rheum 1996;14:263–74.
   PubMed Web of Science ®Google Scholar
• Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis: a computer-assisted analysis of ninety-two patients. Arthritis Rheum 1985;28:249–55.
   PubMed Web of Science ®Google Scholar
• Fergusson RJ, Davidson NM, Nuki G, Crompton GK. Dermato-myositis and rapidly progressive fibrosing alveolitis. Thorax 1983;38:71–2.
   PubMed Web of Science ®Google Scholar
• Targoff IN. Polymyositis and dermatomyositis in adults. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors. Oxford textbook of rheumatology. 2nd ed. Oxford: Oxford University Press; 1998. p. 1249–87.
   Google Scholar
• Nobutoh T, Kohda M, Doi Y, Ueki H. An autopsy case of der-matomyositis with rapidly progressive diffuse alveolar damage. J Dermatol 1998;25:32–6.
   PubMedGoogle Scholar
• Yamanishi Y, Maeda H, Konishi F, Hiyama K, Yamana S, Ishioka S, et al. Dermatomyositis associated with rapidly progressive fatal interstitial pneumonitis and pneumomediastinum. Scand J Ftheumatol 1999;28:58–61.
   PubMed Web of Science ®Google Scholar
• Gruhn WB, Diaz-Buxo JA. Cyclosporine treatment of steroid-resistant interstitial pneumonitis associated with dermatomyositis and polymyositis. J Ftheumatol 1987;14:1045–7.
   Google Scholar
• Maeda K, Kimura R, Komuta K, Igarashi T. Cyclosporine treat-ment for polymyositis/dermatomyositis: is it possible to rescue thedeteriorating cases with interstitial pneumonitis? Scand J Ftheumatol 1997;26:24–9.
   PubMed Web of Science ®Google Scholar
• Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, et al. Corticosteroid-resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Ftheumatol 1999;26:1527–33.
   Google Scholar
• Harigai M, Hara M, Kamatani N, Kashiwazaki S. Nation-wide survey of treatment with cyclosporine A of interstitial pneumonia associated with collagen diseases (in Japanese). Ryumachi 1999;39:819–28.
   PubMedGoogle Scholar
• Euwer RL, Sontheimer RD. Amyopathic dermatomyosis: a review. J Invest Dermatol 1993;100(Suppl):124s–7s.
   Google Scholar
• Hugh Jones P, Lambert AV. A simple standard exercise test and its use for measuring exertion dyspnea. Br Med J 1952;2:65–71.
   Google Scholar
• Murray JF, Matthay MA, Luce JM, Flick R. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720–3.
   PubMed Web of Science ®Google Scholar
• Ishii Y, Kitamura S. The effect of a neutrophil elastase inhibitor 0N05046 for idiopathic interstitial pneumonia. Phase II study (in Japanese). Annual Report of the Ministry of Health and Welfare, Diffuse Pulmonary Disease Research Committee, 1997. p. 43–7.
   Google Scholar
• Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T. Interstitial lung disease in dermatomyositis: clinicopathological study. J Ftheumatol 1987;14:102–7.
   Google Scholar
• Yoshizawa Y, Miyake S, Sumi Y, Hisauchi K, Sato T, Kurup VP. A follow-up study of pulmonary function tests, bronchoalveolar lavage cells, and humoral and cellular immunity in bird fancier's lung. J Allergy Clin Immunol 1995;96:122–9.
   PubMed Web of Science ®Google Scholar
• Ohtani Y, Kojima K, Sumi Y, Sawada M, Inase N, Miyake S, et al. Inhalation provocation tests in chronic bird fancier's lung. Chest 2000;118:1382–9.
   PubMed Web of Science ®Google Scholar
• Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med 1986;80:329–32.
   Google Scholar
• Pearson CM. Polymyositis and dermatomyositis. In: McCarty DJ, editor. Arthritis and allied conditions. 9th ed. Philadelphia: Lea & Febiger; 1979. p. 742.
   Google Scholar
• Fernandes J, Goodwill CJ. Dermatomyositis without apparent myositis, complicated by fibrosing alveolitis. J R Soc Med 1979;72:777–9.
   PubMed Web of Science ®Google Scholar
• Tokiyama K, Tagawa H, Yokota E, Nagasawa K, Kusaba T, Tsuda Y, et al. Two cases of amyopathic dermatomyositis with fatal rap-idly progressive interstitial pneumonitis (in Japanese). Ryumachi 1990;30:204–11.
   PubMedGoogle Scholar
• Toyoshima M, Sato A, Chida K, Hayakawa H, Todate A, Imokawa S, et al. Clinicopathological features of interstitial pneumonia asso-ciated with amyopathic dermatomyositis (in Japanese). Jpn J Thorac Dis 1997;35:281–7.
   Google Scholar
• Santiago MB, Chalhoub M, Pereira ST. Amyopathic dermatomyo-sitis complicated by interstitial pulmonary disease and pneumome-diastinum. J Ftheumatol 1998;25:2042–3.
   Google Scholar
• Nanke Y, Tateishi M, Yamagata H, Hara M, Kamatani N. A case of amyopathic dermatomyositis with rapidly progressive interstitial pneumonitis (in Japanese). Ryumachi 2000;40:705–10.
   Google Scholar
• Hirakata M, Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2000;12:501–8.
   PubMed Web of Science ®Google Scholar
• Nakajima H, Harigai M, Hara M, Hakoda M, Tokuda H, Sakai F, et al. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Ftheumatol 2000;27:1164–70.
   Google Scholar
• Miller FW. Inflammatory myopathies: polymyositis, dermatomyo-sitis, and related conditions. In: Koopman WJ, editor. Arthritis and allied conditions. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1562.
   Google Scholar
• Bandoh S, Fujita J, Ohtsuki Y, Ueda Y, Hojo S, Tokuda M, et al. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis. Ann Rheum Dis 2000;59:257–62.
   PubMed Web of Science ®Google Scholar
• Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727–33.
   PubMed Web of Science ®Google Scholar
• Duncan PE, Griffin JP, Garcia A, Kaplan SB. Fibrosing alveolitis in polymyositis. A review of histologically confirmed cases. Am J Med 1974;57:621–6.
   PubMed Web of Science ®Google Scholar